OVERVIEW

1st RNA Editing Summit 2019 is organized by Hanson Wade and will be held from Nov 19 - 20, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Description:
As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 1st RNA Editing Summit 2019 accelerates the translation and commercialization of RNA editing for an array of research and therapeutic applications.

As the therapeutic potential of RNA editing explodes, discover the fundamental mechanisms of RNA editing, such as recruiting endogenous ADARs with encodable guideRNAs, and learn about the novel approaches being developed to precisely and efficiently deliver intended RNA edits.

Join RNA, functional genomic, cell biology and immuno-oncology experts from large pharma, biotech and academia at the 1st RNA Editing Summit 2019 in the pursuit of translating emerging RNA editing mechanisms into therapeutic reality.

Top 3 benefits of attending:
• Tap into the genetic engineering eruption that is occurring and gain first mover advantage in this fast emerging space learning from leading biotech’s and pioneering academics.
• Discover the fundamental mechanisms of RNA editing and learn about the novel approaches being developed to precisely and efficiently deliver intended RNA edits.
• Explore how RNA Editing can be used as a critical immuno-oncology tool and unravel different industry approaches to utilize or inhibit these enzymes for the treatment of human diseases.

Time: 08:00 - 17:00

Additional details will be posted as soon as information is available.

KEY DATES

Event Start Date
19 Nov, 2019
Event Start Date
Event End Date
20 Nov, 2019
Event End Date

SPECIALITIES

Molecular BiologyGenetics

SUGGESTED HOTELS

CONFERENCE VENUE

LocationRevere Hotel Boston Common
200 Stuart St

RELATED CONFERENCES & LIVE WEBINARS

Oct 26 - 27, 2026 | Paris, ...

Molecular Biology
More actions
FR€350

Oct 26 - 27, 2026 | Paris, ...

Molecular Biology
More actions
FR€499